tradingkey.logo
搜索

Balchem Corp

BCPC
添加自选
168.800USD
-0.090-0.05%
收盘 07/02, 13:00美东报价延迟15分钟
5.42B总市值
34.32市盈率 TTM

关于 Balchem Corp 公司

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

Balchem Corp简介

公司代码BCPC
公司名称Balchem Corp
上市日期Jun 03, 1986
CEOHarris (Theodore L)
员工数量1361
证券类型Ordinary Share
年结日Jun 03
公司地址- -
城市- -
上市交易所NASDAQ OMX - NASDAQ BASIC
国家- -
邮编- -
电话- -
网址- -
公司代码BCPC
上市日期Jun 03, 1986
CEOHarris (Theodore L)

Balchem Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
74.51K
+0.97%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
7.45K
+8.59%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
5.08K
+19.25%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
4.08K
+34.87%
Mr. Olivier Rigaud
Mr. Olivier Rigaud
Independent Director
Independent Director
980.00
+11.22%
Ms. Monica Vicente
Ms. Monica Vicente
Independent Director
Independent Director
980.00
+11.22%
Mr. Matthew D. (Matt) Wineinger
Mr. Matthew D. (Matt) Wineinger
Lead Independent Director
Lead Independent Director
--
--
Mr. Daniel E. Knutson, CPA
Mr. Daniel E. Knutson, CPA
Independent Director
Independent Director
--
--
Mr. C. Martin Bengtsson
Mr. C. Martin Bengtsson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Kathleen B. Fish
Ms. Kathleen B. Fish
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
74.51K
+0.97%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
7.45K
+8.59%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
5.08K
+19.25%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
4.08K
+34.87%
Mr. Olivier Rigaud
Mr. Olivier Rigaud
Independent Director
Independent Director
980.00
+11.22%
Ms. Monica Vicente
Ms. Monica Vicente
Independent Director
Independent Director
980.00
+11.22%

常见问题

Balchem Corp的前五大股东是谁?

Balchem Corp 的前五大股东如下:Mr. Theodore L. (Ted) Harris

有多少机构持有Balchem Corp(BCPC)的股份?

截至2026Q1,共有741家机构持有Balchem Corp的股份,合计持有的股份价值约为28.38M,占公司总股份的88.34%。与2025Q4相比,机构持股有所增加,增幅为-2011669.00。

哪个业务部门对Balchem Corp的收入贡献最大?

在2026Q1,Product Sales Revenue业务部门对Balchem Corp的收入贡献最大,创收1.04B,占总收入的99.82%。